Products for Research Use Only
RegisterLogin

Siponimod hemifumarate

CAT: 0931-T64065-01Size: 25 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T64065-01Size:25 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
1234627-85-0
Target
Others, LPL Receptor
Related Pathways
GPCR/G Protein, Others
Bioactivity
Siponimod (BAF-312) hemifumarate, a selective and potent modulator of sphingosine-1-phosphate (S1P) receptors, can be used in the study of multiple sclerosis (MS) .
Smiles
OC(=O)\C=C\C(O)=O.CCc1cc(ccc1CN1CC(C1)C(O)=O)C(\C)=N\OCc1ccc(C2CCCCC2)c(c1)C(F)(F)F.CCc1cc(ccc1CN1CC(C1)C(O)=O)C(\C)=N\OCc1ccc(C2CCCCC2)c(c1)C(F)(F)F
Molecular Formula
C62H74F6N4O10
Molecular Weight
1149.282
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Chemical Information

Siponimod Fumarate

Siponimod Fumarate is the fumarate salt form of siponimod, an orally bioavailable sphingosine 1-phosphate (S1P) receptor modulator, with potential anti-inflammatory and immunomodulating activities. Upon oral administration, siponimod targets and binds to S1P receptors 1 and 5 on lymphocytes. This prevents the egress of lymphocytes from lymph nodes, thereby reducing both the number of circulating peripheral lymphocytes and the infiltration of lymphocytes into target tissues, such as the central nervous system (CNS). This prevents lymphocyte-mediated immune response and may reduce inflammation. S1P plays a key role in lymphocyte migration from lymphoid tissues. Siponimod does not target S1P receptor 3, the activation of which may be responsible for adverse effects such as bradycardia associated with other S1P receptor modulators.

CAS Number1234627-85-0
PubChem CID46700777
IUPAC Name(E)-but-2-enedioic acid;bis(1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidine-3-carboxylic acid)
Molecular FormulaC62H74F6N4O10
Molecular Weight1149.3
Topological Polar Surface Area199
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count20
Rotatable Bond Count20
Heavy Atom Count82
Formal Charge0
Complexity896
SMILES
CCC1=C(C=CC(=C1)/C(=N/OCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)/C)CN4CC(C4)C(=O)O.CCC1=C(C=CC(=C1)/C(=N/OCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)/C)CN4CC(C4)C(=O)O.C(=C/C(=O)O)\C(=O)O
InChI
InChI=1S/2C29H35F3N2O3.C4H4O4/c2*1-3-21-14-23(10-11-24(21)15-34-16-25(17-34)28(35)36)19(2)33-37-18-20-9-12-26(22-7-5-4-6-8-22)27(13-20)29(30,31)32;5-3(6)1-2-4(7)8/h2*9-14,22,25H,3-8,15-18H2,1-2H3,(H,35,36);1-2H,(H,5,6)(H,7,8)/b2*33-19+;2-1+
InChIKey
JNLIKIBISICTMS-PEJBKAKVSA-N
Chemical Structure
2D Structure
2D structure of Siponimod Fumarate
CAS: 1234627-85-0
CID: 46700777
Formula: C62H74F6N4O10
MW: 1149.3
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight1149.3
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count20
Rotatable Bond Count20
Exact Mass1148.53091354
Monoisotopic Mass1148.53091354
Topological Polar Surface Area199 Ų
Heavy Atom Count82
Formal Charge0
Complexity896
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count3
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count3
Compound Is CanonicalizedYes

Related Products

CatalogName
T6403-01Siponimod
T64175Cobimetinib hemifumarate
T22872-01Isamoltane hemifumarate
T71973-01Gilteritinib hemifumarate
T39094-01MSC2360844 hemifumarate
T23536-01Xamoterol hemifumarate
T0143-01Bisoprolol hemifumarate
T6241-01Quetiapine hemifumarate
T12505PLX5622 hemifumarate
T21911-01Rilmenidine hemifumarate

Alternative Products

CatalogName
GTR19185446-01Siponimod hemifumarate
HY-12355ASiponimod (hemifumarate)
206455Siponimod
B3225-25BAF312 (Siponimod)
S7179-25mgSiponimod (BAF312)
AR-S10437-01Siponimod Trifluoroacetate
CS-EO-02968Siponimod-d5
CS-CX-00610Siponimod D11
AR-S10418-01Siponimod Dimer
AR-S10421-01(Z) -Siponimod

Popular Products